Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Scott

Showing results (231-240 of 242) with videos related to

Pageof 25
Sort By:
BMJ Open|March 21, 2025
Changing primary care capacity in Canada: protocol for a cross-provincial mixed methods studyM Ruth Lavergne, Julie Easley, Agnes Grudniewicz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2026
Antibody Format Matters: A Comparative Analysis of VHH and scFv Domains Reveals Superior In Vivo CAR T Cell Function with VHH DomainsAlexander Kinna, Preeta Datta, Reyisa Bughda, et al.
Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
BMJ Open|September 26, 2019
Practice patterns among early-career primary care (ECPC) physicians and workforce planning implications: protocol for a mixed methods studyM Ruth Lavergne, Laurie J Goldsmith, Agnes Grudniewicz, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of the Intensive Care Society|May 13, 2024
EPidemiology Of Cardiogenic sHock in Scotland (EPOCHS): A multicentre, prospective observational study of the prevalence, management and outcomes of cardiogenic shock in ScotlandAlex Warren, Philip McCall, Alastair Proudfoot, et al.
Zebrafish|June 2, 2016
Restrictions on the Importation of Zebrafish into Canada Associated with Spring Viremia of Carp VirusDavid Hanwell, Sarah A Hutchinson, Chereen Collymore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer ScreeningUsha Menon, Andy Ryan, Jatinderpal Kalsi, et al.
Pageof 25

Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
BMJ Open|March 21, 2025
Changing primary care capacity in Canada: protocol for a cross-provincial mixed methods studyM Ruth Lavergne, Julie Easley, Agnes Grudniewicz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2026
Antibody Format Matters: A Comparative Analysis of VHH and scFv Domains Reveals Superior In Vivo CAR T Cell Function with VHH DomainsAlexander Kinna, Preeta Datta, Reyisa Bughda, et al.
Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
BMJ Open|September 26, 2019
Practice patterns among early-career primary care (ECPC) physicians and workforce planning implications: protocol for a mixed methods studyM Ruth Lavergne, Laurie J Goldsmith, Agnes Grudniewicz, et al.
The Lancet. Oncology|December 15, 2010
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohortIan Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of the Intensive Care Society|May 13, 2024
EPidemiology Of Cardiogenic sHock in Scotland (EPOCHS): A multicentre, prospective observational study of the prevalence, management and outcomes of cardiogenic shock in ScotlandAlex Warren, Philip McCall, Alastair Proudfoot, et al.
Zebrafish|June 2, 2016
Restrictions on the Importation of Zebrafish into Canada Associated with Spring Viremia of Carp VirusDavid Hanwell, Sarah A Hutchinson, Chereen Collymore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer ScreeningUsha Menon, Andy Ryan, Jatinderpal Kalsi, et al.
Pageof 25